UBS AM’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

UBS AM’s Portfolio SYNH Stock Details SYNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-158,242	Closed	-$5.64M	–	2717
2023 Q2	$5.64M	Hold	158,242	–	–	﹤0.01%	1176
2023 Q1	$5.64M	Buy	158,242 +10,653	+7%	+$387K	﹤0.01%	1176
2022 Q4	$5.41M	Sell	147,589 -303	-0.2%	-$12K	﹤0.01%	1142
2022 Q3	$6.97M	Sell	147,892 -71,366	-33%	-$4.61M	﹤0.01%	1086
2022 Q2	$15.7M	Buy	219,258 +1,301	+0.6%	+$95.1K	0.01%	796
2022 Q1	$17.6M	Buy	217,957 +17,704	+9%	+$1.5M	0.01%	873
2021 Q4	$20.6M	Buy	200,253 +2,075	+1%	+$199K	0.01%	892
2021 Q3	$17.3M	Buy	198,178 +984	+0.5%	+$89.1K	0.01%	908
2021 Q2	$17.6M	Buy	197,194 +84,154	+74%	+$7.11M	0.01%	921
2021 Q1	$8.57M	Sell	113,040 -4,846	-4%	-$365K	﹤0.01%	1132
2020 Q4	$8.03M	Buy	117,886 +29,638	+34%	+$1.85M	﹤0.01%	1128
2020 Q3	$4.69M	Buy	88,248 +10,297	+13%	+$613K	﹤0.01%	1176
2020 Q2	$4.54M	Buy	77,951 +8,005	+11%	+$430K	﹤0.01%	1155
2020 Q1	$2.76M	Sell	69,946 -1,323	-2%	-$77.4K	﹤0.01%	1286
2019 Q4	$4.24M	Sell	71,269 -3,259	-4%	-$175K	﹤0.01%	1259
2019 Q3	$3.97M	Buy	74,528 +18,335	+33%	+$941K	﹤0.01%	1299
2019 Q2	$2.87M	Buy	56,193 +7,088	+14%	+$330K	﹤0.01%	1415
2019 Q1	$2.54M	Buy	49,105 +7,142	+17%	+$346K	﹤0.01%	1407
2018 Q4	$1.65M	Buy	41,963 +1,745	+4%	+$81.1K	﹤0.01%	1518
2018 Q3	$2.07M	Buy	40,218 +1,954	+5%	+$95.7K	﹤0.01%	1487
2018 Q2	$1.79M	Buy	38,264 +9,290	+32%	+$385K	﹤0.01%	1551
2018 Q1	$1.03M	Buy	28,974 +1,675	+6%	+$65.6K	﹤0.01%	1771
2017 Q4	$1.19M	Sell	27,299 -4,476	-14%	-$209K	﹤0.01%	1668
2017 Q3	$1.66M	Buy	31,775 +2,053	+7%	+$114K	﹤0.01%	1478
2017 Q2	$1.74M	Sell	29,722 -396	-1%	-$20.6K	﹤0.01%	1416
2017 Q1	$1.38M	Buy	30,118 +6,423	+27%	+$320K	﹤0.01%	1500
2016 Q4	$1.25M	Sell	23,695 -6,386	-21%	-$309K	﹤0.01%	1471
2016 Q3	$1.34M	Buy	30,081 +8,560	+40%	+$371K	﹤0.01%	1546
2016 Q2	$821K	Buy	21,521 +7,889	+58%	+$347K	﹤0.01%	1736
2016 Q1	$562K	Sell	13,632 -2,927	-18%	-$121K	﹤0.01%	1869
2015 Q4	$803K	Hold	16,559	–	–	﹤0.01%	1828
2015 Q3	$662K	Buy	16,559 +10,759	+186%	+$470K	﹤0.01%	1874
2015 Q2	$233K	Buy	+5,800	New	+$200K	﹤0.01%	2517

Other funds holding SYNH

Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $4.34B AUM 19.31% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Natixis Advisors Boston, Massachusetts $71.9B AUM 28.03% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Nomura Asset Management Tokyo, Japan $38.8B AUM 30.94% 1-Year Est. Return

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

CFB

Cullen/Frost Bankers San Antonio, Texas $8.81B AUM 22.47% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

UBS AM's SYNH Position: Q3 2023 in Review

UBS AM sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2023, closing a stake of 158,242 shares — an estimated $5.64M sold.

UBS AM first reported a position in SYNH in Q2 2015 and held it in 33 quarters. The position peaked at $20.6M in Q4 2021. 10 funds tracked by Wall St. Rank hold SYNH as of Q3 2023.

UBS AM reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
UBS AM sold 158,242 Syneos Health, Inc. Class A Common Stock shares in Q3 2023, an estimated $5.64M.
UBS AM first reported a position in Syneos Health, Inc. Class A Common Stock in Q2 2015 and held it in 33 quarters.
UBS AM's Syneos Health, Inc. Class A Common Stock position peaked at $20.6M in Q4 2021.
10 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2023.

Based on UBS AM's 13F filing for Q3 2023, filed 13 Nov 2023.